Glenmark Pharmaceuticals Ltd
GLENMARK

887.90

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

885.60

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

883.80

Open ()
Open Interest
(Contracts)
VWAP ()
Day's Vol
(shares)
Detailed Quote

View

Buy
Reco. Price
Rs 900.00

Last updated on 06-Jan-2017

We maintain BUY backed by expected EPS growth of 18% CAGR over FY16-18. We believe the FCCB issuance will help the company to reduce forex volatility in its debt obligations and bring down the cost of debt. Increasing market share in Teneligliptin & Mupricon cream, are likely to be the key drivers for the stock’s performance. We value stock at 34x FY18E earnings. (Target Price - 1,026)
Detailed View
50 DMA (.)
896.36
100 DMA (.)
901.20
200 DMA (.)
862.02
Weekly Range (.)
870.00
909.35
Monthly Range (.)
870.00
954.90
52 Weeks Range (.)
671.10
994.00
Detailed Chart